117 related articles for article (PubMed ID: 16969094)
21. Sphingosine kinase 1 is a relevant molecular target in gastric cancer.
Fuereder T; Hoeflmayer D; Jaeger-Lansky A; Rasin-Streden D; Strommer S; Fisker N; Hansen BJ; Crevenna R; Wacheck V
Anticancer Drugs; 2011 Mar; 22(3):245-52. PubMed ID: 21360847
[TBL] [Abstract][Full Text] [Related]
22. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines.
Ni P; Xu W; Zhang Y; Chen Q; Li A; Wang S; Xu S; Zhou J
Curr Cancer Drug Targets; 2015; 14(9):850-9. PubMed ID: 25348020
[TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
[TBL] [Abstract][Full Text] [Related]
24. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
[TBL] [Abstract][Full Text] [Related]
26. [Differential gene expression of the inhibitor of apoptosis proteins in docetaxel-resistant gastric cancer cells].
Wang TT; Wei J; Qian XP; Yu LX; Liu BR
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):573-7. PubMed ID: 19102932
[TBL] [Abstract][Full Text] [Related]
27. Modulation of Mcl-1 transcription by serum deprivation sensitizes cancer cells to cisplatin.
Senichkin VV; Kopeina GS; Prokhorova EA; Zamaraev AV; Lavrik IN; Zhivotovsky B
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):557-566. PubMed ID: 29203282
[TBL] [Abstract][Full Text] [Related]
28. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
29. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
[TBL] [Abstract][Full Text] [Related]
31. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
Brotin E; Meryet-Figuière M; Simonin K; Duval RE; Villedieu M; Leroy-Dudal J; Saison-Behmoaras E; Gauduchon P; Denoyelle C; Poulain L
Int J Cancer; 2010 Feb; 126(4):885-95. PubMed ID: 19634140
[TBL] [Abstract][Full Text] [Related]
32. Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.
Simonin K; Brotin E; Dufort S; Dutoit S; Goux D; N'diaye M; Denoyelle C; Gauduchon P; Poulain L
Mol Cancer Ther; 2009 Nov; 8(11):3162-70. PubMed ID: 19887550
[TBL] [Abstract][Full Text] [Related]
33. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
34. MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer.
Zhang R; Li Y; Dong X; Peng L; Nie X
Med Oncol; 2014 Dec; 31(12):347. PubMed ID: 25416050
[TBL] [Abstract][Full Text] [Related]
35. The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells.
Hu CJ; Wang B; Tang B; Chen BJ; Xiao YF; Qin Y; Yong X; Luo G; Zhang JW; Zhang D; Li S; He F; Yang SM
Biochim Biophys Acta; 2015 Mar; 1849(3):290-9. PubMed ID: 25482013
[TBL] [Abstract][Full Text] [Related]
36. Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism.
Maeda S; Sugiura T; Saikawa Y; Kubota T; Otani Y; Kumai K; Kitajima M
Cancer Sci; 2004 Aug; 95(8):679-84. PubMed ID: 15298732
[TBL] [Abstract][Full Text] [Related]
37. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1.
Sly LM; Hingley-Wilson SM; Reiner NE; McMaster WR
J Immunol; 2003 Jan; 170(1):430-7. PubMed ID: 12496428
[TBL] [Abstract][Full Text] [Related]
38. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
[TBL] [Abstract][Full Text] [Related]
39. Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
Ma Y; Cress WD; Haura EB
Mol Cancer Ther; 2003 Jan; 2(1):73-81. PubMed ID: 12533675
[TBL] [Abstract][Full Text] [Related]
40. Antisense targeting of Mcl-1 has therapeutic potential in gastric cancer.
Zangemeister-Wittke U; Huwiler A
Cancer Biol Ther; 2006 Oct; 5(10):1355-6. PubMed ID: 17172809
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]